Orally Delivered Microencapsulated Live Probiotic Formulation Lowers Serum Lipids in Hypercholesterolemic Hamsters
- 1 April 2009
- journal article
- Published by Mary Ann Liebert Inc in Journal of Medicinal Food
- Vol. 12 (2), 310-319
- https://doi.org/10.1089/jmf.2008.0166
Abstract
Elevated serum cholesterol is a major risk factor for coronary artery disease. Nutritional therapies such as probiotics have been suggested to manage elevated cholesterol. This study investigates the cholesterol and triglyceride lowering potential of a microencapsulated feruloyl esterase-producing Lactobacillus fermentum 11976 (LF11976) probiotic formulation. Male Bio F(1)B hamsters were assigned to two groups to receive either the microcapsule probiotic formulation (containing LF11976 cells at 12.51 log colony-forming units/mL) or placebo formulation (empty) microcapsules, twice daily, by oral gavage for 18 weeks. For the duration of the study, animals were fed a hypercholesterolemic diet. Serum total cholesterol, low-density lipoprotein (LDL) cholesterol, and the atherogenic index were 21.36%, 31.43%, and 32.59% lower in the group gavaged with the microencapsulated probiotic formulation than in the placebo control group after 18 weeks (P < .05). Histology studies showed reduced progression of atherosclerotic lesions in animals treated with microencapsulated LF11976 as compared to control animals. Treatment with microencapsulated LF11976 formulation produces significant reductions in serum total cholesterol, LDL cholesterol, and serum triglyceride levels in diet-induced hypercholesterolemic hamsters. Findings suggest the potential of the oral microencapsulated probiotic cell formulation as a functional nutritional alternative for managing excessive serum cholesterol and triglyceride levels.Keywords
This publication has 50 references indexed in Scilit:
- Preparation and in vitro analysis of microencapsulated live Lactobacillus fermentum 11976 for augmentation of feruloyl esterase in the gastrointestinal tractBiotechnology and Applied Biochemistry, 2008
- Probiotic capsules do not lower plasma lipids in young women and menEuropean Journal of Clinical Nutrition, 2007
- Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterolNutrition, Metabolism and Cardiovascular Diseases, 2006
- Ferulic acid alleviates lipid peroxidation in diabetic ratsPhytotherapy Research, 2004
- Antioxidant activity and hypoglycemic effect of ferulic acid in STZ‐induced diabetic mice and KK‐Ay miceBioFactors, 2004
- Protective effects of ferulic acid on hyperlipidemic diabetic ratsActa Diabetologica, 2003
- Long-term consumption of fermented dairy products over 6 months increases HDL cholesterolEuropean Journal of Clinical Nutrition, 2002
- CorrespondenceAtherosclerosis, 1998
- Nutritional and biochemical aspects of the hypolipidemic action of rice bran oil: a review.Journal of the American College of Nutrition, 1991
- Mass fragmentographic determination of ferulic acid in plasma after oral administration of .GAMMA.-oryzanol.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982